National Health (Weighted average disclosed price – April 2015 reduction day) Amendment Determination 2015 (No. 1) (PB 9 of 2015) (Cth)

PB 9 of 2015

National Health (Weighted average disclosed price –April 2015 reduction day) Amendment Determination 2015 (No.1)

National Health Act 1953

I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated: 25 February 2015

FELICITY MCNEILL

First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1. Name of Determination

(1)     This Determination is the National Health (Weighted average disclosed price – April 2015 reduction day) Amendment Determination 2015 (No.1).

(2)     This Determination may also be cited as PB 9 of 2015.

1. Commencement

   This Determination commences on the day after it is registered.

1. Amendments to PB 97 of 2014

   Schedule 1 amends the National Health (Weighted average disclosed price – April 2015 reduction day) Determination 2014 (PB 97 of 2014).

Schedule 1       Amendments

[1]     Schedule 1

omit:

152	Aspirin	Tablet 100 mg	Oral	Astrix	0.96
153	Aspirin	Tablet 100 mg	Oral	Mayne Pharma Aspirin	0.96
154	Aspirin	Tablet 100 mg	Oral	Spren 100	0.96
155	Aspirin	Tablet, dispersible, 300 mg	Oral	Solprin	1.23

[2]     Schedule 1

omit:

582	Exemestane	Tablet 25 mg	Oral	APO-Exemestane	71.33
583	Exemestane	Tablet 25 mg	Oral	Aromasin	71.33
584	Exemestane	Tablet 25 mg	Oral	Exaccord	71.33
585	Exemestane	Tablet 25 mg	Oral	Exemestane AN	71.33
586	Exemestane	Tablet 25 mg	Oral	Exemestane GH	71.33
587	Exemestane	Tablet 25 mg	Oral	Exemestane Pfizer	71.33
588	Exemestane	Tablet 25 mg	Oral	Exemestane Sandoz	71.33
589	Exemestane	Tablet 25 mg	Oral	Exemestane-GA	71.33

substitute:

582	Exemestane	Tablet 25 mg	Oral	APO-Exemestane	84.64
583	Exemestane	Tablet 25 mg	Oral	Aromasin	84.64
584	Exemestane	Tablet 25 mg	Oral	Exaccord	84.64
585	Exemestane	Tablet 25 mg	Oral	Exemestane AN	84.64
586	Exemestane	Tablet 25 mg	Oral	Exemestane GH	84.64
587	Exemestane	Tablet 25 mg	Oral	Exemestane Pfizer	84.64
588	Exemestane	Tablet 25 mg	Oral	Exemestane Sandoz	84.64
589	Exemestane	Tablet 25 mg	Oral	Exemestane-GA	84.64

[3]     Schedule 1

omit:

1080 Macrogol 3350 Oral liquid 13.125 g with electrolytes, 500 mL Oral Movicol Liquid 6.37

substitute:

1080 Macrogol 3350 Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL Oral Movicol Liquid 6.37

[4]     Schedule 1

omit:

1259	Nevirapine	Tablet 200 mg	Oral	Nevipin	166.60
1260	Nevirapine	Tablet 200 mg	Oral	Nevirapine Alphapharm	166.60
1261	Nevirapine	Tablet 200 mg	Oral	Nevirapine RBX	166.60
1262	Nevirapine	Tablet 200 mg	Oral	Viramune	166.60
1263	Nevirapine	Tablet 400 mg (extended release)	Oral	Viramune XR	166.60

substitute:

1259	Nevirapine	Tablet 200 mg	Oral	Nevipin	198.09
1260	Nevirapine	Tablet 200 mg	Oral	Nevirapine Alphapharm	198.09
1261	Nevirapine	Tablet 200 mg	Oral	Nevirapine RBX	198.09
1262	Nevirapine	Tablet 200 mg	Oral	Viramune	198.09
1263	Nevirapine	Tablet 400 mg (extended release)	Oral	Viramune XR	198.09

[5]     Schedule 1

after:

2075 Tramadol Tablet (sustained release) containing tramadol hydrochloride 200 mg Oral Zydol SR 200 4.14

omit:

2076 Tramadol Tablet (sustained release) containing tramadol hydrochloride 50 mg Oral Tramal SR 50 1.76

[6]     Schedule 2

after:

99 Ampicillin Powder for injection 500 mg (as sodium) Injection Ibimicyn 3.09

insert:

99A	Aspirin	Tablet 100 mg	Oral	Astrix	1.07
99B	Aspirin	Tablet 100 mg	Oral	Mayne Pharma Aspirin	1.07
99C	Aspirin	Tablet 100 mg	Oral	Spren 100	1.07
99D	Aspirin	Tablet, dispersible, 300 mg	Oral	Solprin	1.37

[7]     Schedule 2

omit:

1416 Sodium chloride I.V. infusion 154 mmol per L. 1 L Injection Baxter Healthcare Pty Ltd 1.27

substitute:

1416 Sodium chloride I.V. infusion 154 mmol per L, 1 L Injection Baxter Healthcare Pty Ltd 1.27